Use of neuregulin-4 for treatment of inflammatory bowel disease and necrotizing enterocolitis

摘要

The invention provides methods, pharmaceutical compositions and kits for treating, inhibiting and/or reducing the severity of inflammatory bowel disease and necrotizing enterocolitis in a subject in need thereof by administering an effective amount of a composition comprising an activator of ErbB4.